136 related articles for article (PubMed ID: 22048231)
21. A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
Turpie AG; Eriksson BI; Lassen MR; Bauer KA
J South Orthop Assoc; 2002; 11(4):182-8. PubMed ID: 12597061
[TBL] [Abstract][Full Text] [Related]
22. Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety.
Kwong LM; Muntz JE
Am J Orthop (Belle Mead NJ); 2002 Nov; 31(11 Suppl):16-20. PubMed ID: 12463579
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.
Deitelzweig SB; Becker R; Lin J; Benner J
Thromb Haemost; 2008 Nov; 100(5):810-20. PubMed ID: 18989525
[TBL] [Abstract][Full Text] [Related]
24. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
[TBL] [Abstract][Full Text] [Related]
25. New oral anticoagulants in venous thromboembolism prophylaxis in orthopaedic patients: are they really better?
Huo MH
Thromb Haemost; 2011 Jul; 106(1):45-57. PubMed ID: 21544312
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.
Shorr AF; Kwong LM; Sarnes M; Happe L; Farrelly E; Mody-Patel N
Thromb Res; 2007; 121(1):17-24. PubMed ID: 17449088
[TBL] [Abstract][Full Text] [Related]
27. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
28. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
Huisman MV; Quinlan DJ; Dahl OE; Schulman S
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):652-60. PubMed ID: 20923996
[TBL] [Abstract][Full Text] [Related]
29. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
Enyart JJ; Jones RJ
Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
[TBL] [Abstract][Full Text] [Related]
30. Safety evaluation of enoxaparin in currently approved indications.
Meneveau N
Expert Opin Drug Saf; 2009 Nov; 8(6):745-54. PubMed ID: 19860536
[TBL] [Abstract][Full Text] [Related]
31. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
32. Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs.
Zufferey PJ; Samama CM; Rosencher N
Thromb Haemost; 2010 Dec; 104(6):1083-4. PubMed ID: 20886198
[No Abstract] [Full Text] [Related]
33. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
34. State-of-the-art review: Assessing the safety profiles of new anticoagulants for major orthopedic surgery thromboprophylaxis.
Hull RD; Yusen RD; Bergqvist D
Clin Appl Thromb Hemost; 2009; 15(4):377-88. PubMed ID: 19608549
[TBL] [Abstract][Full Text] [Related]
35. Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis.
Bauer KA
Am J Orthop (Belle Mead NJ); 2002 Nov; 31(11 Suppl):4-10. PubMed ID: 12463577
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.
Bottaro FJ; Elizondo MC; Doti C; Bruetman JE; Perez Moreno PD; Bullorsky EO; Ceresetto JM
Thromb Haemost; 2008 Jun; 99(6):1104-11. PubMed ID: 18521515
[TBL] [Abstract][Full Text] [Related]
37. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboprophylaxis: reducing needlestick injury.
Rogers J
Nurs Stand; 2010 Aug 11-17; 24(49):35-41. PubMed ID: 20831111
[TBL] [Abstract][Full Text] [Related]
39. New oral anticoagulant drugs in the prevention of venous thromboembolism in orthopedic surgery: what implications for neuraxial anesthesia?
Cossu AP
Minerva Anestesiol; 2013 Jun; 79(6):703-4. PubMed ID: 23306399
[No Abstract] [Full Text] [Related]
40. Extension of anticoagulation after venous thromboembolism - risk factors influencing the decision.
Schulman S
Hamostaseologie; 2008; 28(3):110-9. PubMed ID: 18521488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]